Status:
COMPLETED
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial AIM 1
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Moi University
Conditions:
Malaria
Febrile Illness
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
The TESTsmART Trial consists of two main aims. The overall goal of the two aims is to investigate the impact of malaria rapid diagnostic test (mRDT) subsidies and conditional artemisinin combination t...
Detailed Description
RATIONALE: From previous studies and implementation experiences, we know that consumption of ACTs increases as the price declines. Declining prices of ACTs create a trade-off between access and targe...
Eligibility Criteria
Inclusion
- Participants with fever or history of fever or malaria like illness
- Individual with malaria-like illness must be present at recruitment
- 1 year of age or older
Exclusion
- Any individual with signs of severe illness requiring immediate referral
- Individuals who have taken an antimalarial in the last seven days, including for the current illness
- Individuals who already have a prescription from a facility or medical provider
- Pregnant women will be enrolled and offered an mRDT, but will be advised to seek treatment through a health care provider.
Key Trial Info
Start Date :
March 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2019
Estimated Enrollment :
842 Patients enrolled
Trial Details
Trial ID
NCT03810014
Start Date
March 28 2019
End Date
October 31 2019
Last Update
November 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moi University
Eldoret, Kenya